Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Day

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Seminars in Liver Disease|September 18, 2015
The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2Quentin M Anstee, Christopher P Day
The New England Journal of Medicine|October 1, 2010
Risk of cardiovascular disease in patients with nonalcoholic fatty liver diseaseGiovanni Targher, Christopher P Day, Enzo Bonora
Journal of Hepatology|March 30, 2007
A coffee with your brandy, Sir?Stuart F W Kendrick, Christopher P Day
Gut|December 17, 2010
Risk of all-cause and cardiovascular mortality in patients with chronic liver diseaseGiovanni Targher, Giacomo Zoppini, Christopher P Day
Gastroenterology|March 29, 2011
Polymorphism in the farnesyl diphosphate farnesyl transferase 1 gene and nonalcoholic fatty liver disease severityStefano Ballestri, Christopher P Day, Ann K Daly
Gastroenterology|February 14, 2016
Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver DiseaseQuentin M Anstee, Devanshi Seth, Christopher P Day
Journal of Hepatology|July 5, 2011
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic reviewChristian Thoma, Christopher P Day, Michael I Trenell
Nature Reviews. Gastroenterology & Hepatology|March 20, 2013
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosisQuentin M Anstee, Giovanni Targher, Christopher P Day
BMJ (Clinical Research Ed.)|July 20, 2011
How big a problem is non-alcoholic fatty liver disease?Quentin M Anstee, Stuart McPherson, Christopher P Day
Current Opinion in Gastroenterology|March 17, 2015
Nonalcoholic fatty liver disease: new treatmentsTimothy Hardy, Quentin M Anstee, Christopher P Day
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Seminars in Liver Disease|September 18, 2015
The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2Quentin M Anstee, Christopher P Day
The New England Journal of Medicine|October 1, 2010
Risk of cardiovascular disease in patients with nonalcoholic fatty liver diseaseGiovanni Targher, Christopher P Day, Enzo Bonora
Journal of Hepatology|March 30, 2007
A coffee with your brandy, Sir?Stuart F W Kendrick, Christopher P Day
Gut|December 17, 2010
Risk of all-cause and cardiovascular mortality in patients with chronic liver diseaseGiovanni Targher, Giacomo Zoppini, Christopher P Day
Gastroenterology|March 29, 2011
Polymorphism in the farnesyl diphosphate farnesyl transferase 1 gene and nonalcoholic fatty liver disease severityStefano Ballestri, Christopher P Day, Ann K Daly
Gastroenterology|February 14, 2016
Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver DiseaseQuentin M Anstee, Devanshi Seth, Christopher P Day
Journal of Hepatology|July 5, 2011
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic reviewChristian Thoma, Christopher P Day, Michael I Trenell
Nature Reviews. Gastroenterology & Hepatology|March 20, 2013
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosisQuentin M Anstee, Giovanni Targher, Christopher P Day
BMJ (Clinical Research Ed.)|July 20, 2011
How big a problem is non-alcoholic fatty liver disease?Quentin M Anstee, Stuart McPherson, Christopher P Day
Current Opinion in Gastroenterology|March 17, 2015
Nonalcoholic fatty liver disease: new treatmentsTimothy Hardy, Quentin M Anstee, Christopher P Day
Pageof 13